US 8383805
RNAi modulation of SCAP and therapeutic uses thereof
granted A61PA61P1/00A61P1/16
Quick answer
US patent 8383805 (RNAi modulation of SCAP and therapeutic uses thereof) held by The Board of Regents of the University of Texas System expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P1/00, A61P1/16, A61P3/00, A61P3/04